Ilypsa
Health Care
USVP Contact:
Jon Root
Ilypsa (acquired by Amgen) is a therapeutics platform spinout of Symx that develops novel polymer-based, orally bioavailable therapies to treat renal failure and metabolic disorders.
Health Care
USVP Contact:
Jon Root
Ilypsa (acquired by Amgen) is a therapeutics platform spinout of Symx that develops novel polymer-based, orally bioavailable therapies to treat renal failure and metabolic disorders.